• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶 A 与 CFTR 复合物的结构:磷酸化和非催化激活的机制。

The structures of protein kinase A in complex with CFTR: Mechanisms of phosphorylation and noncatalytic activation.

机构信息

Laboratory of Membrane Biology and Biophysics, The Rockefeller University, New York, NY 10065.

Department of Biochemistry, Semmelweis University, Budapest H-1094, Hungary.

出版信息

Proc Natl Acad Sci U S A. 2024 Nov 12;121(46):e2409049121. doi: 10.1073/pnas.2409049121. Epub 2024 Nov 4.

DOI:10.1073/pnas.2409049121
PMID:39495916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11573500/
Abstract

Protein kinase A (PKA) is a key regulator of cellular functions by selectively phosphorylating numerous substrates, including ion channels, enzymes, and transcription factors. It has long served as a model system for understanding the eukaryotic kinases. Using cryoelectron microscopy, we present complex structures of the PKA catalytic subunit (PKA-C) bound to a full-length protein substrate, the cystic fibrosis transmembrane conductance regulator (CFTR)-an ion channel vital to human health. CFTR gating requires phosphorylation of its regulatory (R) domain. Unphosphorylated CFTR engages PKA-C at two locations, establishing two "catalytic stations" near to, but not directly involving, the R domain. This configuration, coupled with the conformational flexibility of the R domain, permits transient interactions of the eleven spatially separated phosphorylation sites. Furthermore, we determined two structures of the open-pore CFTR stabilized by PKA-C, providing a molecular basis to understand how PKA-C stimulates CFTR currents even in the absence of phosphorylation.

摘要

蛋白激酶 A(PKA)通过选择性磷酸化众多底物,包括离子通道、酶和转录因子,来调节细胞功能,它长期以来一直是理解真核激酶的模型系统。我们使用冷冻电子显微镜,呈现了 PKA 催化亚基(PKA-C)与全长蛋白底物囊性纤维化跨膜电导调节剂(CFTR)结合的复合物结构,CFTR 是对人类健康至关重要的离子通道。CFTR 的门控需要其调节(R)域的磷酸化。未磷酸化的 CFTR 在两个位置与 PKA-C 结合,在 R 域附近建立两个“催化站”,但不直接涉及 R 域。这种构象,加上 R 域的构象灵活性,允许十一个空间分离的磷酸化位点的瞬时相互作用。此外,我们还确定了两个由 PKA-C 稳定的开放孔 CFTR 结构,为理解 PKA-C 如何在没有磷酸化的情况下刺激 CFTR 电流提供了分子基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e99c/11573500/b9d32b7d4975/pnas.2409049121fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e99c/11573500/182492a4b2ba/pnas.2409049121fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e99c/11573500/797471dc4b1f/pnas.2409049121fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e99c/11573500/e9d643f5a205/pnas.2409049121fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e99c/11573500/b9d32b7d4975/pnas.2409049121fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e99c/11573500/182492a4b2ba/pnas.2409049121fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e99c/11573500/797471dc4b1f/pnas.2409049121fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e99c/11573500/e9d643f5a205/pnas.2409049121fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e99c/11573500/b9d32b7d4975/pnas.2409049121fig05.jpg

相似文献

1
The structures of protein kinase A in complex with CFTR: Mechanisms of phosphorylation and noncatalytic activation.蛋白激酶 A 与 CFTR 复合物的结构:磷酸化和非催化激活的机制。
Proc Natl Acad Sci U S A. 2024 Nov 12;121(46):e2409049121. doi: 10.1073/pnas.2409049121. Epub 2024 Nov 4.
2
Structural determinants of protein kinase A essential for CFTR channel activation.蛋白激酶 A 激活 CFTR 通道的结构决定因素。
Proc Natl Acad Sci U S A. 2024 Nov 12;121(46):e2407728121. doi: 10.1073/pnas.2407728121. Epub 2024 Nov 4.
3
Protein kinase A phosphorylation potentiates cystic fibrosis transmembrane conductance regulator gating by relieving autoinhibition on the stimulatory C terminus of the regulatory domain.蛋白激酶 A 的磷酸化作用通过减轻调节域的刺激 C 端对自身的抑制作用,增强囊性纤维化跨膜电导调节蛋白的门控作用。
J Biol Chem. 2020 Apr 3;295(14):4577-4590. doi: 10.1074/jbc.RA119.008427. Epub 2020 Feb 26.
4
AMP-activated protein kinase phosphorylation of the R domain inhibits PKA stimulation of CFTR.R结构域的AMP激活蛋白激酶磷酸化抑制蛋白激酶A对囊性纤维化跨膜传导调节因子的刺激作用。
Am J Physiol Cell Physiol. 2009 Jul;297(1):C94-101. doi: 10.1152/ajpcell.00677.2008. Epub 2009 May 6.
5
Regulation of recombinant cardiac cystic fibrosis transmembrane conductance regulator chloride channels by protein kinase C.蛋白激酶C对重组心脏囊性纤维化跨膜传导调节因子氯离子通道的调控
Biophys J. 1999 Apr;76(4):1972-87. doi: 10.1016/S0006-3495(99)77356-X.
6
Simple binding of protein kinase A prior to phosphorylation allows CFTR anion channels to be opened by nucleotides.蛋白激酶 A 先于磷酸化而发生简单结合,使 CFTR 阴离子通道能够被核苷酸打开。
Proc Natl Acad Sci U S A. 2020 Sep 1;117(35):21740-21746. doi: 10.1073/pnas.2007910117. Epub 2020 Aug 17.
7
Influence of phosphorylation by protein kinase A on CFTR at the cell surface and endoplasmic reticulum.蛋白激酶A磷酸化对细胞表面及内质网中囊性纤维化跨膜传导调节因子的影响。
Biochim Biophys Acta. 1999 Dec 6;1461(2):275-83. doi: 10.1016/s0005-2736(99)00163-7.
8
Severed channels probe regulation of gating of cystic fibrosis transmembrane conductance regulator by its cytoplasmic domains.切割通道探究囊性纤维化跨膜电导调节因子门控受其胞质结构域的调控。
J Gen Physiol. 2000 Sep;116(3):477-500. doi: 10.1085/jgp.116.3.477.
9
Protein kinase A regulates ATP hydrolysis and dimerization by a CFTR (cystic fibrosis transmembrane conductance regulator) domain.蛋白激酶A通过囊性纤维化跨膜传导调节因子(CFTR)结构域来调节ATP水解和二聚化。
Biochem J. 2004 Feb 15;378(Pt 1):151-9. doi: 10.1042/BJ20021428.
10
Molecular structure of the ATP-bound, phosphorylated human CFTR.ATP 结合磷酸化的人 CFTR 的分子结构。
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12757-12762. doi: 10.1073/pnas.1815287115. Epub 2018 Nov 20.

引用本文的文献

1
Structure of CFTR bound to (R)-BPO-27 unveils a pore-blockage mechanism.与(R)-BPO-27结合的CFTR结构揭示了一种孔道阻塞机制。
Nat Commun. 2025 Aug 1;16(1):7059. doi: 10.1038/s41467-025-62199-7.
2
Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators.高效CFTR调节剂时代囊性纤维化个性化医疗的进展
Mol Cell Pediatr. 2025 May 5;12(1):6. doi: 10.1186/s40348-025-00194-0.
3
A Structural Mechanism for Noncanonical GPCR Signal Transduction in the Hedgehog Pathway.刺猬信号通路中非典型GPCR信号转导的结构机制

本文引用的文献

1
PKA regulation of neuronal function requires the dissociation of catalytic subunits from regulatory subunits.蛋白激酶 A(PKA)对神经元功能的调节需要催化亚基与调节亚基的分离。
Elife. 2024 Nov 7;13:RP93766. doi: 10.7554/eLife.93766.
2
Structural identification of a selectivity filter in CFTR.CFTR 中选择性过滤器的结构鉴定。
Proc Natl Acad Sci U S A. 2024 Feb 27;121(9):e2316673121. doi: 10.1073/pnas.2316673121. Epub 2024 Feb 21.
3
Real-time observation of functional specialization among phosphorylation sites in CFTR.实时观察 CFTR 中磷酸化位点的功能特化。
bioRxiv. 2024 Nov 1:2024.10.31.621410. doi: 10.1101/2024.10.31.621410.
J Gen Physiol. 2023 Apr 3;155(4). doi: 10.1085/jgp.202213216. Epub 2023 Jan 25.
4
Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update.FDA 批准的小分子蛋白激酶抑制剂的特性:2023 年更新。
Pharmacol Res. 2023 Jan;187:106552. doi: 10.1016/j.phrs.2022.106552. Epub 2022 Nov 17.
5
Molecular structures reveal synergistic rescue of Δ508 CFTR by Trikafta modulators.分子结构揭示了 Trikafta 调节剂对 Δ508 CFTR 的协同拯救作用。
Science. 2022 Oct 21;378(6617):284-290. doi: 10.1126/science.ade2216. Epub 2022 Oct 20.
6
The structural basis for regulation of the glutathione transporter Ycf1 by regulatory domain phosphorylation.调控谷胱甘肽转运蛋白 Ycf1 的结构基础:由调控域磷酸化介导。
Nat Commun. 2022 Mar 11;13(1):1278. doi: 10.1038/s41467-022-28811-w.
7
Molecular pathology of the R117H cystic fibrosis mutation is explained by loss of a hydrogen bond.R117H 囊性纤维化突变的分子病理学可通过氢键的丢失来解释。
Elife. 2021 Dec 6;10:e74693. doi: 10.7554/eLife.74693.
8
Triple Therapy for Cystic Fibrosis -Gating and -Residual Function Genotypes.囊性纤维化-门控和-残留功能基因型的三联疗法。
N Engl J Med. 2021 Aug 26;385(9):815-825. doi: 10.1056/NEJMoa2100665.
9
Structure of Ycf1p reveals the transmembrane domain TMD0 and the regulatory region of ABCC transporters.Ycf1p 的结构揭示了 ABCC 转运蛋白的跨膜结构域 TMD0 和调节区。
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2025853118.
10
Kinase drug discovery 20 years after imatinib: progress and future directions.伊马替尼发现 20 年后的激酶药物研发:进展与未来方向
Nat Rev Drug Discov. 2021 Jul;20(7):551-569. doi: 10.1038/s41573-021-00195-4. Epub 2021 May 17.